American journal of respiratory and critical care medicine
Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.
Mesenchymal stromal (stem) cell therapy: an emerging immunomodulatory strategy for the adjunctive treatment of sepsis.
Surgical lung biopsy over bronchoalveolar lavage in chronic hypersensitivity pneumonitis.
The bronchial microbiome and asthma phenotypes.
Type 2 immune responses in obese individuals with asthma.
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012.
Reply: idiopathic pulmonary fibrosis: a degenerative disease requiring a regenerative approach.
Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing.
Regulation and function of epithelial secreted phospholipase A2 group X in asthma.
